Search Results - "Lin FPY"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

    Authors: Siu DHW Lin FPY Thomas DM et al.

    Source: Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1965-1974. Date of Electronic Publication: 2026 Jun 16.

    Publication Type: Journal Article

    Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

    Save to List
  2. 2

    Bridging AI development with clinical relevance-A scoping review of skin cancer models since CLEAR Derm. Where to next?

    Authors: Tan E Tran M Rademaker M et al.

    Source: The Australasian journal of dermatology [Australas J Dermatol] 2024 May; Vol. 65 (3), pp. e56-e58. Date of Electronic Publication: 2023 Dec 25.

    Publication Type: Letter; Scoping Review

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-0960 (Electronic) Linking ISSN: 00048380 NLM ISO Abbreviation: Australas J Dermatol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice.

    Authors: Epstein RJ Lin FPY Brink RA et al.

    Source: PloS one [PLoS One] 2023 Apr 13; Vol. 18 (4), pp. e0284327. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Can cancer go green? It's up to us.

    Authors: Epstein RJ Gu Y Lin FPY

    Source: Frontiers in oncology [Front Oncol] 2023 Feb 22; Vol. 13, pp. 1074091. Date of Electronic Publication: 2023 Feb 22 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

    PDF Full Text
    Save to List
  5. 5

    Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials.

    Authors: Siu DHW Lin FPY Cho D et al.

    Source: JCO precision oncology [JCO Precis Oncol] 2024 Jan; Vol. 8, pp. e2300317.

    Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

    Save to List
  6. 6

    Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery.

    Authors: Tan E Lim S Lamont D et al.

    Source: JAAD international [JAAD Int] 2023 Nov 07; Vol. 14, pp. 39-47. Date of Electronic Publication: 2023 Nov 07 (Print Publication: 2024).

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774762 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3287 (Electronic) Linking ISSN: 26663287 NLM ISO Abbreviation: JAAD Int Subsets: PubMed not MEDLINE

    Save to List

Search Tools: